Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Sallie Mae CFO to Speak at Morgan Stanley U.S. Financials Conference
-
Granite’s Brunswick Facility to Support East William Street Complete Project in Carson City
-
Establishment Labs to Present at Jefferies Global Healthcare Conference
-
CareDx Announces Repurchase of 5% of Outstanding Shares
-
LENNAR CORPORATION TO BROADCAST ITS SECOND QUARTER EARNINGS CALL ON JUNE 17, 2025
-
Karman Space & Defense Hosts United States Representative Gil Cisneros Jr. (CA-31) for Facility Tour Highlighting Critical Role in U.S. Space Access and National Security
-
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress
-
Link Begins Production of High-Capacity Loading Ramp
-
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
-
Rocket Lab Schedules Third Electron Launch in 24 Days to Deploy Next Mission for iQPS
-
NCR Voyix to Participate in Upcoming Investor Conferences
-
MarketAxess to Participate in the Morgan Stanley U.S. Financials Conference
-
Couchbase Announces New Employee Inducement Grants
-
Annual General Shareholders’ Meeting of Natuzzi S.p.A.
-
LandingAI Launches Agentic Document Extraction on Snowflake Marketplace to Tackle Complex Document Workflows and Understanding
-
HeartCore Signs 15th Go IPO Contract
-
CBL International Limited Announces Share Repurchase Program Repurchase Reflects the Board’s Confidence in Long-Term Growth
-
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ingersoll Rand to Participate in Upcoming Investor Conference
-
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
-
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
-
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
-
LandingAI Named Snowflake Startup Program Data Cloud Product Partner of the Year
-
Green Bay Packaging Invests More Than $1 Billion in Morrilton, Arkansas Facility
-
Trinity Place Holdings Inc. Reports First Quarter Financial Results
-
Jabil’s Third Quarter of Fiscal Year 2025 Earnings Announcement Set
-
2025 Atlantic Hurricane Season: CenterPoint Energy emphasizes preparedness with critical resiliency efforts completed before June 1; urges customers to have an emergency plan and practice that plan
-
Jim Belushi Launches Belushi's Farm Signature Strains at Bloom Cannabis Dispensaries
-
Strathmore Announces Private Placement up to $1M
-
HarrisX Research Honored with Two 2025 Effie Awards, Fuels Award-Winning Saucony Marathumb Challenge
-
Powermax Minerals Completes Phase 1 Exploration Program at Cameron Rare Earth Project
-
Innventure to Participate in Upcoming Investor Conferences
-
OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS SECOND QUARTER OF FISCAL YEAR 2025 RESULTS
-
ONEOK Acquires Remaining Interest in Delaware Basin JV
-
TriNet Recognized as a 2025-2026 Best Company to Work For by U.S. News & World Report
-
Guidewire Announces Third Quarter Fiscal Year 2025 Financial Results
-
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information
-
ONE Gas to Participate in Mizuho Mid-Cap Utilities Conference
-
Invesco Ltd. to Participate in the Morgan Stanley U.S. Financials Conference
-
Pacific Coast Oil Trust Announces Monthly Net Profits Interest Calculations
-
Moelis & Company Management to Speak at the 2025 Morgan Stanley US Financials Conference
-
Microchip Technology to Present at the Bank of America 2025 Global Technology Conference
-
J.Jill, Inc. Announces Quarterly Dividend
-
Cable One Announces CEO Succession Plan
-
Reinsurance Group of America Ranked #196 on the 2025 Fortune 500 List
-
NevGold Adds More Significant Oxide Gold-Antimony Results: 1.47 g/t AuEq Over 74.7 Meters (0.23% Antimony And 0.45 g/t Au), Including 3.59 g/t AuEq Over 18.2 Meters (0.60% Antimony And 0.92 g/t Au),
-
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
-
Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
